CD45+CD11b+ myeloid cells represented ~20% of live tumor cells isolated on day 21 from Klf4(f/f) and ~29% of Klf4(f/f);Lys-Cre Hi-Myc PCa recipients, p = 0.07 (Fig 2B, right). This evidence concerns the gene KLF4 and neoplasm.